SCHEMBL8301696

SCHEMBL8301696

CC(C)(C)NS(=O)(=O)CCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14624491 0.93
SCHEMBL2630537 0.79 HPGD (0.40)
SCHEMBL11502601 0.77 APP (0.41)
SCHEMBL2197372 0.77 FAAH (0.43)
SCHEMBL635978 0.77 ALDH1A1 (0.30)
SCHEMBL21690990 0.77
SCHEMBL21690630 0.76
SCHEMBL21690862 0.76
SCHEMBL6493220 0.76 CA2 (0.32)
SCHEMBL6831855 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013059265-A1 A COMPOUND FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-25 WO disclosed
US-20090112021-A1 Preparation of cyclopropyl sulfonylamides ROCHE PALO ALTO LLC 2009-04-30 US disclosed
WO-2004094452-A2 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-11-04 WO disclosed